Uncategorised - Page 13

Tourette Syndrome Pipeline 2026: Investigational Therapies, Clinical Trial Advances, and Key Regulatory Developments by DelveInsight

According to DelveInsight’s latest evaluation, the global Tourette syndrome treatment pipeline features more than 6 prominent companies actively advancing over 6 investigational therapies. The comprehensive assessment covers ongoing clinical trials, therapeutic candidates, mechanisms of action, administration routes, and notable developmental milestones. The
25 March 2026

The Global Next-Generation Sequencing Market Size is Estimated to Grow at a CAGR of 18.96% by 2030, estimates DelveInsight

DelveInsight’s Next-Generation Sequencing Market Insights Report 2030 provides the current and forecast market analysis, individual leading Next-Generation Sequencing Companies market shares, challenges, Next-Generation Sequencing Market Drivers, barriers, trends, and key market Next-Generation Sequencing companies in the market. To read more about the
17 June 2026

Motor Neuron Disease Pipeline 2026: Emerging Gene Therapies, Stem Cell Innovations, and Precision Medicine Approaches Transform the Treatment Landscape

Motor Neuron Disease pipeline is witnessing significant advancements driven by innovative gene therapies, regenerative medicine approaches, and disease-modifying treatments from companies including Biohaven Pharmaceuticals, Prilenia Therapeutics, Sanofi, Roche, Cytokinetics, Amylyx Pharmaceuticals, and others. DelveInsight’s “Motor Neuron Disease Pipeline Insight 2026“ report provides
17 June 2026
1 11 12 13 14 15 34